Deutsch English Français

Contact

EP3440087

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP3440087

EP3440087 - THIAZOLOPYRIDINE DERIVATIVES AS GPR119 AGONISTS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 16.06.2023 Database last updated on 22.05.2024
Former	The patent has been granted Status updated on 08.07.2022
Former	Grant of patent is intended Status updated on 16.03.2022
Former	Examination is in progress Status updated on 18.10.2019
Former	Request for examination was made Status updated on 11.01.2019
Former	The international publication has been made Status updated on 13.10.2017
Former	unknown Status updated on 07.06.2017
Most recent event Tooltip	19.04.2024	Lapse of the patent in a contracting state New state(s): IE	published on 22.05.2024 [2024/21]
Applicant(s)	For all designated states Mankind Pharma Ltd. 208 Okhla Industrial Estate, Phase 3 New Delhi 110020 / IN
	[2022/32]
Former [2019/07]	For all designated states MANKIND PHARMA LTD 208 Okhla Industrial Estate Phase 3 New Delhi - 110020 / IN
Inventor(s)	01 / PATIL, Rakesh, Ishwar Mankind Research Center 191-e Sector 4-II Imt Manesar Haryana 122 050 / IN
	02 / VERMA, Jeevan Mankind Research Center 191-e Sector 4-II Imt Manesar Haryana 122 050 / IN
	03 / SHAH, Dharmesh Mankind Research Center 191-e Sector 4-II Imt Manesar Haryana 122 050 / IN
	04 / ALI, Sazid Mankind Research Center 191-e Sector 4-II Imt Manesar Haryana 122 050 / IN
	05 / BAPURAM, Srinivasa, Reddy Mankind Research Center 191-e Sector 4-II Imt Manesar Haryana 122 050 / IN
	06 / RAI, Santosh, Kumar Mankind Research Center 191-e Sector 4-II Imt Manesar Haryana 122 050 / IN
	07 / KUMAR, Anil Mankind Research Center 191-e Sector 4-II Imt Manesar Haryana 122 050 / IN
	[2022/31]
Former [2019/07]	01 / PATIL, Rakesh, Ishwar Mankind Research Center 191-e Sector 4-ii Imt Manesar Haryana 122 020 / IN
	02 / VERMA, Jeevan Mankind Research Center 191-e Sector 4-11 Imt Manesar Haryana 122 050 HI / IN
	03 / SHAH, Dharmesh Mankind Research Center 191-e Sector 4-ii Imt Manesar Haryana 122 050 / IN
	04 / ALI, Sazid Mankind Research Center 191-e Sector 4-ii Imt Manesar Haryana 122 050 / IN
	05 / BAPURAM, Srinivasa, Reddy Mankind Research Center 191-e Sector 4-11 Imt Manesar Haryana 122 050 / IN
	06 / RAI, Santosh, Kumar Mankind Research Center 191-e Sector 4-11 Imt Manesar Haryana 122 050 / IN
	07 / KUMAR, Anil Mankind Research Center 191-e Sector 4-11 Imt Manesar Haryana 122 050 / IN
Representative(s)	Müller-Boré & Partner Patentanwälte PartG mbB Friedenheimer Brücke 21 80639 München / DE
	[2019/07]
Application number, filing date	17726352.2	05.04.2017
	[2019/07]
	WO2017IB00471
Priority number, date	IN201611012425	08.04.2016 Original published format: IN201611012425
	[2019/07]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2017175068
	Date:	12.10.2017
	Language:	EN
	[2017/41]
	Type:	A1 Application with search report
	No.:	EP3440087
	Date:	13.02.2019
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.10.2017 takes the place of the publication of the European patent application.
	[2019/07]
	Type:	B1 Patent specification
	No.:	EP3440087
	Date:	10.08.2022
	Language:	EN
	[2022/32]
Search report(s)	International search report - published on:	EP	12.10.2017
Classification	IPC:	C07D513/04, A61K31/437, A61P3/10	[2019/07]
	CPC:	C07D513/04 (EP,RU,US); A61K31/437 (RU); A61K31/506 (US); A61K31/522 (US); A61P3/00 (EP); A61P3/04 (EP,US); (+) A61P3/10 (EP,RU,US); A61P43/00 (EP); C07D473/02 (US) (-)
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/07]
Extension states	BA	Not yet paid
	ME	Not yet paid
Validation states	MA	Not yet paid
	MD	Not yet paid
Title	German:	THIAZOLOPYRIDINE DERIVATE ALS GPR119 AGONISTEN	[2022/10]
	English:	THIAZOLOPYRIDINE DERIVATIVES AS GPR119 AGONISTS	[2019/07]
	French:	DERIVES DE THIAZOLOPYRIDINE COMME DES AGONISTES DE GPR119	[2022/10]
	Former [2019/07]	THIAZOLOPYRIDINDERIVATE ALS GPR119-AGONISTEN
	Former [2019/07]	DÉRIVÉS DE LA THIAZOLOPYRIDINE EN TANT QU'AGONISTES DU RÉCEPTEUR GPR119
Entry into regional phase	31.10.2018	National basic fee paid
	31.10.2018	Designation fee(s) paid
	31.10.2018	Examination fee paid
Examination procedure	31.10.2018	Examination requested [2019/07]
	31.10.2018	Date on which the examining division has become responsible
	16.05.2019	Amendment by applicant (claims and/or description)
	17.10.2019	Despatch of a communication from the examining division (Time limit: M04)
	11.02.2020	Reply to a communication from the examining division
	26.05.2020	Despatch of a communication from the examining division (Time limit: M04)
	14.09.2020	Reply to a communication from the examining division
	12.01.2021	Despatch of a communication from the examining division (Time limit: M04)
	04.02.2021	Reply to a communication from the examining division
	11.06.2021	Despatch of a communication from the examining division (Time limit: M04)
	05.10.2021	Reply to a communication from the examining division
	17.03.2022	Communication of intention to grant the patent
	23.06.2022	Receipt of the translation of the claim(s)
	30.06.2022	Fee for grant paid
	30.06.2022	Fee for publishing/printing paid
Opposition(s)	11.05.2023	No opposition filed within time limit [2023/29]
Fees paid	Renewal fee
	24.04.2019	Renewal fee patent year 03
	30.04.2020	Renewal fee patent year 04
	15.04.2021	Renewal fee patent year 05
	29.03.2022	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	AL	10.08.2022
	AT	10.08.2022
	CZ	10.08.2022
	DK	10.08.2022
	EE	10.08.2022
	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	MC	10.08.2022
	NL	10.08.2022
	PL	10.08.2022
	RO	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	SI	10.08.2022
	SK	10.08.2022
	SM	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	IS	10.12.2022
	PT	12.12.2022
	IE	05.04.2023
	LU	05.04.2023
	BE	30.04.2023
	CH	30.04.2023
	LI	30.04.2023
	[2024/21]
Former [2024/12]	AL	10.08.2022
	AT	10.08.2022
	CZ	10.08.2022
	DK	10.08.2022
	EE	10.08.2022
	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	MC	10.08.2022
	NL	10.08.2022
	PL	10.08.2022
	RO	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	SI	10.08.2022
	SK	10.08.2022
	SM	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	IS	10.12.2022
	PT	12.12.2022
	LU	05.04.2023
	BE	30.04.2023
	CH	30.04.2023
	LI	30.04.2023
Former [2024/09]	AL	10.08.2022
	AT	10.08.2022
	CZ	10.08.2022
	DK	10.08.2022
	EE	10.08.2022
	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	MC	10.08.2022
	NL	10.08.2022
	PL	10.08.2022
	RO	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	SI	10.08.2022
	SK	10.08.2022
	SM	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	IS	10.12.2022
	PT	12.12.2022
	LU	05.04.2023
	CH	30.04.2023
	LI	30.04.2023
Former [2024/08]	AL	10.08.2022
	AT	10.08.2022
	CZ	10.08.2022
	DK	10.08.2022
	EE	10.08.2022
	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	MC	10.08.2022
	NL	10.08.2022
	PL	10.08.2022
	RO	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	SI	10.08.2022
	SK	10.08.2022
	SM	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	IS	10.12.2022
	PT	12.12.2022
	LU	05.04.2023
Former [2024/04]	AL	10.08.2022
	AT	10.08.2022
	CZ	10.08.2022
	DK	10.08.2022
	EE	10.08.2022
	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	NL	10.08.2022
	PL	10.08.2022
	RO	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	SI	10.08.2022
	SK	10.08.2022
	SM	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	IS	10.12.2022
	PT	12.12.2022
	LU	05.04.2023
Former [2023/37]	AL	10.08.2022
	AT	10.08.2022
	CZ	10.08.2022
	DK	10.08.2022
	EE	10.08.2022
	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	NL	10.08.2022
	PL	10.08.2022
	RO	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	SI	10.08.2022
	SK	10.08.2022
	SM	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	IS	10.12.2022
	PT	12.12.2022
Former [2023/29]	AL	10.08.2022
	AT	10.08.2022
	CZ	10.08.2022
	DK	10.08.2022
	EE	10.08.2022
	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	NL	10.08.2022
	PL	10.08.2022
	RO	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	SK	10.08.2022
	SM	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	IS	10.12.2022
	PT	12.12.2022
Former [2023/23]	AT	10.08.2022
	CZ	10.08.2022
	DK	10.08.2022
	EE	10.08.2022
	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	NL	10.08.2022
	PL	10.08.2022
	RO	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	SK	10.08.2022
	SM	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	IS	10.12.2022
	PT	12.12.2022
Former [2023/22]	AT	10.08.2022
	CZ	10.08.2022
	DK	10.08.2022
	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	NL	10.08.2022
	PL	10.08.2022
	RO	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	SM	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	IS	10.12.2022
	PT	12.12.2022
Former [2023/21]	DK	10.08.2022
	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	NL	10.08.2022
	PL	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	SM	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	IS	10.12.2022
	PT	12.12.2022
Former [2023/20]	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	NL	10.08.2022
	PL	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	SM	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	IS	10.12.2022
	PT	12.12.2022
Former [2023/12]	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	NL	10.08.2022
	PL	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	IS	10.12.2022
	PT	12.12.2022
Former [2023/11]	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	NL	10.08.2022
	PL	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	PT	12.12.2022
Former [2023/10]	FI	10.08.2022
	HR	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	NL	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	NO	10.11.2022
	GR	11.11.2022
	PT	12.12.2022
Former [2023/09]	FI	10.08.2022
	LT	10.08.2022
	LV	10.08.2022
	NL	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	NO	10.11.2022
	PT	12.12.2022
Former [2023/08]	FI	10.08.2022
	LT	10.08.2022
	NL	10.08.2022
	RS	10.08.2022
	SE	10.08.2022
	NO	10.11.2022
Cited in	International search	[Y]WO2011140160 (BRISTOL MYERS SQUIBB CO [US], et al) [Y] 2-32* see compounds of claim 1 as GRP119 agonists, especially examples 51, 52, 227 to 229, and examples 275 to 299 *;
		[XY]WO2012080476 (BOEHRINGER INGELHEIM INT [DE], et al) [X] 1,25,27-32 * see compounds 1, 3 and 4 on p. 35 and examples 1 to 4, 18, 113, 118, 121, 124 and 166 as inhibitors of GPR119 * [Y] 2-32
	by applicant	- T.SOGA ET AL., BIOCHEM. BIOPHYS. RES. COMMUN., (2005), page 326

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 34p